LigronBio
Newark · Founded 2023
About LigronBio
LigronBio focuses on developing innovative biotech solutions aimed at transforming medical research and patient care. The company specializes in rationally designing and delivering molecular glue-based targeted therapeutics for various disease-causing agents. LigronBio leverages computational chemistry to advance its research and development efforts, contributing significantly to the field of biotechnology.
Company Facts
- Founded: 2023
- Legal name: LigronBio Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2026)
- Website: ligronbio.com
Social Profiles
Canonical: https://fsome.com/organization/ligronbio-8328430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.